M. Kulke
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 8
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 1
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- David P. Ryan (4 shared papers)Keith Stuart (2 shared papers)Charles S. Fuchs (2 shared papers)David C. Christiani (4 shared papers)Geoffrey Liu (4 shared papers)Rebecca S. Heist (3 shared papers)Li Su (3 shared papers)Kofi Asomaning (3 shared papers)
- Journals
- Carcinogenesis (4 papers)Journal of Clinical Oncology (4 papers)Cancer (1 paper)Neuroendocrinology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
M. Kulke
13 papers receiving 344 citations
Peers
Comparison fields: 5 of 35
- Hepatology 53
- Oncology 182
- Cancer Research 86
- Neurology 85
- Epidemiology 126
Countries citing papers authored by M. Kulke
This map shows the geographic impact of M. Kulke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kulke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kulke more than expected).
Fields of papers citing papers by M. Kulke
This network shows the impact of papers produced by M. Kulke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kulke. The network helps show where M. Kulke may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Kulke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 68 | |
| 2 | 2010 | 62 | |
| 3 | 2005 | 57 | |
| 4 | 2008 | 55 | |
| 5 | 2009 | 47 | |
| 6 | 2014 | 19 | |
| 7 | 2010 | 19 | |
| 8 | 2009 | 12 | |
| 9 | 2004 | 6 | |
| 10 | NETTER-1 Phase III Trial : Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors | 2017 | 2 |
| 11 | 2017 | 1 | |
| 12 | 2016 | 1 | |
| 13 | 2004 | 1 |
About M. Kulke
M. Kulke is a scholar working on Oncology, Epidemiology, Neurology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 350 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Research Studies (4 papers), Neuroblastoma Research and Treatments (4 papers), Gastric Cancer Management and Outcomes (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Peptidase Inhibition and Analysis (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hepatology (53 citations), Oncology (182 citations), Cancer Research (86 citations), Neurology (85 citations) and Epidemiology (126 citations). M. Kulke has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include David P. Ryan, Keith Stuart, Charles S. Fuchs, David C. Christiani, Geoffrey Liu, Rebecca S. Heist, Li Su, Kofi Asomaning, Craig C. Earle and Haesook Kim. Their work appears in journals such as Carcinogenesis, Journal of Clinical Oncology, Cancer, Neuroendocrinology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.